






































Generalized life history theory postulates a trade-off 
between development and maintenance explaining the 
considerable variation of traits like age at maturation, 
age at first reproductive event, number of offspring, size 
and lifespan across and within species [1-3]. It is 
debated whether the variation in human lifespan can 
also be explained by such trade-offs. Observational 
studies in women have shown early and above average 
fecundity to come at a cost of longevity [4-8]. The life 
history of men has no distinct mark of the end of 
development as menarche in women, but negative 
correlations between number of offspring  and life-span 
after age 50 have also been reported for males [7, 8]. 
This could be explained as males invest more in physical 
 
 





































strength and growth, which is associated with 
attractiveness and dominance, two traits important for 
male fitness [9, 10].  
 
Professional athletes push their physical performance to 
the maximum and keep accurate track of these 
achievements. Consequently, their personal record is an 
accurate representation of the age of their peak 
performance. Under the assumption that professional 
athletes train at maximum intensity, this peak 
performance is an accurate read-out of the maximal 
physiological capacity of the individual. Because athletes 
compete intensely, the rank of peak performances is an 
accurate comparison of these maximal physiological 
capacities of athletes. According to theory of life history 
regulation, the period before the peak performance could 














Life history  theory postulates a  trade‐off between development and maintenance. This  trade‐off  is observed
when  comparing  life  histories  of  different  animal  species.  In  humans,  however,  it  is  debated  if  variation  in
longevity is explained by differences in developmental traits. Observational studies found a trade‐off between
early and high  fecundity and  longevity  in women. Development encompasses more  than  fecundity and also





This  is  the  first  time a  life history  trade‐off between physical performance and  longevity has been  found  in
humans.  This  finding  deepens  our  understanding  of  early  developmental  influences  on  the  variation  of
longevity in humans. 
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be considered as development, while the decline in 
physical capabilities after setting a personal record is a 




We used a unique historical cohort of 1055 Olympic 
track and field athletes from 41 different nationalities 
from the Olympic Games from 1896 through 1936 [13]. 
Track and field is a large group of similar sports for 
individual performance where the results are measured 
on a continuous scale. Technological advancements 
contribute only little to basic body functions like 
running, throwing and jumping, which are critically 
dependent on physical strength and coordination. 
Athletic games are therefore an ideal group of sports to 
use in this study. Of these Olympic athletes 958 were 
men and 97 women, competing in 58 disciplines. Most 
historical athletes competed in several disciplines and 
therefore we had information on 2320 personal records. 
Mean age at personal record was 24.9 years (SD 3.8). 
The year of birth ranged between 1864 and 1913, and 
the year of death ranged between 1901 and 2010. Mean 
age at death was 72.1 years (SD 16.9). (See 
Supplementary Information). 
 
To compare peak performance of athletes from 
different disciplines and sexes we standardized age at, 
and rank of the personal record per discipline and sex. 
Athletes who had a peak performance one standard 
deviation earlier showed 17-percent increased 
mortality rates compared to those who reached their 
personal record later in life (95% CI 8-26%, P<0.001). 
Independent of the age of their personal record, 
athletes who ranked one standard deviation higher than 
their peers showed 11-percent increased mortality rates 
compared to those who were ranked lower (95% CI 1-
22%, p=0.025). 
 
Figure 1 presents outcomes of various additional 
analyses. First, we analyzed males and females 
separately. Because of the small number of women in 
the early Olympic Games under study here, the risk 
estimates for women have very wide confidence 
intervals, but were not significantly different from men. 
Second, to exclude the influence of accidental causes of 
mortality directly related to professional sports, we 
analyzed survival from age 50 onwards. The outcomes 
did not differ. Third, instead of compiling their multiple 
personal records, we only analyzed the personal record 
in the athlete’s primary discipline, the highest ranking 
discipline, which provided similar outcomes. Fourth, we 
performed analyses in which we standardized the 
personal records not per Olympic discipline but per 
cardiovascular intensity category as classified by the 
American college of cardiology, and per category as 
classified by the IAAF as we have done earlier [14-16]. 
The estimates were unaffected. Finally, we considered 
whether the outcomes could have been influenced by 
any kind of performance enhancing drugs. The first 
doping that was proven effective was developed in 
1935; we therefore assumed that before that year an 
effect of doping was excluded [17, 18]. Using the 92% 
of the observations that were achieved before 1935 
yielded similar results (Figure 1). It is important to note 
that cocaine was available since the first Olympic 
Games and could have played a role in the association.  
 
Life history regulation presumes a compromise between 
variations in the age at, and the extent of physical 
development and longevity (see Figure 2A) [19]. Figure 
2 also presents the average age at death depending on 
the age and the rank of the personal record. Since 
hazard ratios of mortality for women were not 
significant associated with age or rank of personal 
record, the following estimates were calculated in males 
only. Male athlete’s age at death increased from 73.4 
(SE 1.3) years in those who had their peak performance 
in the 25% youngest age range to 77.9 (SE 1.2) years in 
athletes who reached their personal record in the 25% 
oldest age range (panel B, p<0.001). Panel C shows the 
association between the rank of the personal record and 
the age at death. The age at death decreased from 76.8 
(SE 1.7) years in those who had their peak performance 
in the 25% lowest ranks to 74.1 (SE 1.4) years in male 
athletes who reached their personal record in the 25% 
highest ranks (p=0.028). Panel D shows the joint effect 
of age at, and rank of the personal record. We found 
that the mean age at death was lowest (72.8, SE 1.4) for 
those male athletes whose personal record was in the 
earlier half of age and better half of rank. Male athletes 
who peaked at a later age and had a relatively minor 
rank died at a mean age of 77.5 (SE 1.2), resulting in a 
4.7 (SE 1.4) year difference in life expectancy between 




Several factors have to be considered when interpreting 
the present findings. First, differences in socioeconomic 
status could have distorted the observations as wealthier 
athletes may have had better training and therefore 
gained better personal records at an earlier age. An 
affluent environment during development is not only 
likely to contribute to earlier and better physical 
performance, wealthy people on average live longer 
than poor people. We did not have information on the 
socioeconomic position of the athletes, but differences 
are unlikely to explain for the observed trade-off, for 
they would have worked in the opposite direction and,  
  













































if anything, they may have masked the associations 
and any true biological relation would even be 
stronger. We also had no information on the height of 
athletes. 
 
Early cessation of training and competition of 
individual athletes could have resulted in an 
underestimation of the age, and the rank of the personal 
record. Personal records however, have been recorded 
not only at the Olympic Games but also at every other 













































were determined to maximize their performance over a 
prolonged period and would only stop prematurely in 
rare instances. Even if early cessation was frequent, it 
would have weakened the observed association between 
peak performance and age at death and again, any true 
relation would be stronger than we observed here. 
 
According to expectation, we observed a gradual 
increase in life expectancy of athletes from later birth 
cohorts (data not shown). Moreover, a recent year of 
birth was also related to a better personal record at an 
Figure 1. Hazard ratio (HR) for mortality of all Olympic athletes under study and several additional analyses.  (A) Hazard
ratio per standard deviation younger age at personal  record and  (B) per standard deviation higher of  rank of personal  record. Hazard
ratios were derived from a multivariate left truncated Cox’ regression model, adjusted for nationality, sex, year of birth and respectively







www.aging‐us.com                    1824                                                      AGING (Albany  NY) 
earlier age. This ongoing professionalization of sports 
thus masked the observed trade-off; we therefore 
adjusted for birth cohort. 
 
It is difficult to interpret the outcomes among women. 
One possibility is that there is a sex dimorphism and the 
effect is smaller in women, but we were not able to 
study this properly because of the relatively small 
number of female athletes. The alternative is that the 
variance is greater but the effect size is not different. It 
has already been shown that early sexual maturation and 
high fertility of females, which can also be considered a 
peak physical performance, come at a longevity cost [4-









































the average lifespan of fertile women is reduced by fatal 
consequences of pregnancy and childbirth.  Moreover, 
experimental models and observations in humans also 
provide evidence that increases in fecundity come with 
a longevity cost [7, 8, 20, 21].   
 
Whereas previous studies on the cost of sexual 
development and success could only reliably be 
estimated in women, we here show for the first time that 
early and extraordinary peaks in physical performance 
trades off at longevity in men. Physical excellence and 
sports may have a direct cost due to intense training and 
fierce competition, especially when there is a high risk 
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is less likely that these direct costs explain the observed 
trade-off between early and extraordinary physical 
performance and longevity, since we showed a similar 
trade off when analyzing residual life expectancy from 
age 50. This finding supports the idea that early and 
extraordinary peak performance comes with a higher 
pace of ageing [22, 23]. It is tempting to speculate about 
the underlying biological mechanisms of this 
developmental constraint. Some have suggested that 
growth and subsequently, larger size, result in a body 
which costs more energy to maintain, explaining the 
higher pace of ageing [24, 25]. The mTOR pathway, 
which regulates growth in early life and pace of ageing 
in late life, is a potential molecular pathway that can 
explain for the observed trade off [26-28]. Others have 
suggested that hormonal regulation of development and 
maintenance could play a role, as has been observed for 
the GH-IGF signaling pathway explaining the size-life 
span trade off in domestic dogs, and the muscle mass-
immune competence trade-off mediated by testosterone 
observed in primates and other species [10, 29-32]. All 
mechanistic explanations are plausible and it needs to 
be studied which pathways are causal, and at which we 






This study is an observational cohort study to 
investigate the effect of the age at, and relative rank of 





Data on year of birth, year of death, discipline, year of 
personal record, performance score of personal record 
and nationality were retrieved from the continuously 
updated and most comprehensive online database on 
Olympic athletes: Sports Reference database, in April 
2014 [13]. We used this database previously to 
determine the difference in mortality between 
disciplines with different cardiovascular intensity [16]. 
We included all Olympic track and field athletes with a 
known personal record.  This group consisted of 3671 
athletes. First, we excluded 2274 athletes who were 
born after 1913 to ensure that we had a cohort of 
individuals with a complete life history. Second, we 
excluded 126 athletes with an unknown date of birth 
and 216 athletes with an unknown age of death. In an 
additional analysis, we excluded athletes who died 
before age 50 (N=120), to minimize the effect of 
survival bias and extrinsic or accidental causes of 
mortality. For one of the analyses, we excluded all 
personal records set after the year 1935, effectively 
before the effective doping became available. Recording 
of personal records was not bound to the Olympic 
Games and also include every official competition, 




The track and field category consisted of 58 disciplines. 
In the throwing and jumping disciplines we used 
distance as a measure, in the running disciplines we 
converted time over a fixed distance to average speed 
for reasons of comparison, and in the pentathlon and 
decathlon we used the number of points. Variation in 
the number of points in the pentathlon and decathlon 
was high enough to be a good reflection of the athlete’s 
performance.  
 
The performance score of personal record was average 
speed (m s-1) for the running or walking disciplines, 
distance (m) for the throwing and jumping disciplines or 
number of points for the pentathlon and decathlon. 
 
When categorising the various disciplines per 
cardiovascular intensity category we used the 
classification of sports published in the Journal of 
American college of cardiology, as we have used before 
[15, 16]. In the analysis where we grouped multiple 
disciplines according to the International Association of 
Athletics Federation (IAAF) classification before stan-
dardization, we categorized the disciplines in a short, 




For means of comparison between disciplines we 
standardized age and performance score of the personal 
records. We divided the deviation from the mean age at 
personal record of the discipline and sex for each 
discipline and sex separately. The same was done for 
the performance score of the personal record to derive 
the relative rank of the personal record. Additionally, 
we grouped personal records per cardiovascular 
intensity category or per IAAF category, as described 
earlier, and standardized age and performance score in 
these groups to derive an alternative method for 
estimating the relative age and rank of the personal 
record. 
 
Most athletes had more than one personal record and 
had therefore more than one age and performance score 
of personal record. For the primary analysis we 
calculated the average age and rank of the personal 
record for each of the disciplines, all after standardising. 
As an additional analysis we used the best personal 
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record of an athlete, their primary discipline, using the 
record with the highest rank. 
 
We used a left truncated cox proportional hazard model 
to calculate hazard ratios for mortality from the age of the 
peak performance forward. We used estimated marginal 
means from a linear mixed model to estimate the mean 
age at death in groups. The linear mixed model was 
applied on the subset of 844 male athletes who died after 
age 50, to artificially left truncate the linear mixed model. 
All estimates were adjusted for sex, year of birth and 
nationality where possible. 
 
All analyses were performed using IBM SPSS Statistics 




Data provided by OlyMADMen, led by Hilary Evans, 
Arild Gjerde, Jeroen Heijmans, and Bill Mallon. 




Study concept and design: PvdV, DvB. Statistical 
analyses: all authors. Interpretation of results: all 
authors. Drafting of the manuscript: all authors. 
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Table S1. Characteristics of included athletes 
 
Athletes (n) 1055 
       Male (n) 958 
       Female (n) 97 
Year of birth (median, range) 1897 (1864-1913) 
Year of death (median, range) 1969 (1901-2010) 
Age at death (mean, SD) 72.1 (16.9) 
Personal records (n) 2320 
Personal records per athlete (median, range) 2 (1-10) 
Age at personal record (mean, SD) 24.9 (3.8) 
Disciplines (n) 58 
Nationalities (n) 41 
SD=Standard deviation 
